MARSHALL WACE, LLP - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 198 filers reported holding ROYALTY PHARMA PLC in Q4 2020. The put-call ratio across all filers is 2.07 and the average weighting 1.8%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$4,472,943
-91.9%
164,810
-90.9%
0.01%
-91.7%
Q2 2023$55,535,530
+129.2%
1,806,621
+168.6%
0.11%
+111.8%
Q1 2023$24,231,256
+39.5%
672,530
+55.6%
0.05%
+34.2%
Q3 2022$17,368,000
+496.8%
432,250
+479.0%
0.04%
+533.3%
Q1 2022$2,910,000
-61.7%
74,655
-60.9%
0.01%
-57.1%
Q4 2021$7,605,000
-82.5%
190,846
-84.1%
0.01%
-92.2%
Q3 2021$43,440,000
+3428.8%
1,201,980
+4008.6%
0.18%
+2150.0%
Q3 2020$1,231,00029,2550.01%
Other shareholders
ROYALTY PHARMA PLC shareholders Q4 2020
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$92,052,20447.04%
Indie Asset Partners, LLC 433,000$11,751,62011.84%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,095,745$111,158,5196.01%
Advanced Portfolio Management, LLC 230,000$6,242,2005.25%
Compound Global Advisors, LLC 626,412$17,000,8223.73%
Geo Capital Gestora de Recursos Ltd 135,079$3,6663.39%
TORRAY INVESTMENT PARTNERS LLC 412,633$11,198,8601.98%
Overbrook Management Corp 298,712$8,107,0441.89%
Silicon Valley Community Foundation 358,270$9,723,4481.18%
Greytown Advisors Inc. 74,601$2,024,6711.12%
View complete list of ROYALTY PHARMA PLC shareholders